LCN2 and breast carcinoma: Recent studies have reported increased LCN2 expression in various human pathologies, including kidney diseases [8] and obesity [9], as well as solid tumors [10, 11] and other cancers, such as leukemia [12], breast cancer [13], intrahepatic cholangiocarcinoma [14] and liver cancer [15].